Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

The company has maintained a presence in Saudi Arabia for the past decade, expanding its retail pharmacy format into the ...

Huawei's Watch D2, launched in November 2024, is priced at 2,988 yuan ($409) in China. Equipped with features like blood ...

SHANGHAI - 111, Inc. (NASDAQ: YI), a healthcare platform company in China, has regained compliance with the Nasdaq's minimum ...

BuzzRx, a free prescription savings service that allows users to instantly find the lowest price on their medication at pharmacies nationwide, is proud to announce the launch of the first annual ...

Not only is the day care surgery unit at Uckfield Community set to close, the on-site pharmacy will cease operation next ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Santa Rosa County will spend opioid settlement dollars to help people jailed for drug crimes continue treatment and recovery ...

Two bills now in the state Senate would clamp down on Pharmacy Benefit Managers, a kind of intermediary between drug companies and local pharmacies.

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.